FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096659 [Registered on: 30/10/2025] Trial Registered Prospectively
Last Modified On: 29/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Assessing pathological changes in the ovary after menopause 
Scientific Title of Study   Comparative analysis of stromal fibrosis and ovarian reserve in premenopausal and postmenopausal women undergoing oophorectomy: an observational study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Namratha S 
Designation  Junior resident 
Affiliation  AIIMS, Bibinagar 
Address  AIIMS, Bibinagar Rangapur village Bibingar mandal Telangana- 508126

Hyderabad
TELANGANA
508126
India 
Phone  8618436408  
Fax    
Email  namratha125@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR Mishu Mangla  
Designation  Associate professor  
Affiliation  AIIMS, Bibinagar 
Address  Department of OBY AIIMS, Bibinagar Rangapur village
Bibingar mandal Telangana- 508126
Hyderabad
TELANGANA
508126
India 
Phone  9493980850  
Fax    
Email  mishusingla83@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mishu Mangla  
Designation  Associate professor  
Affiliation  AIIMS, Bibinagar 
Address  Department of OBGY AIIMS, Bibinagar Rangapur village
Bibinagar mandal hyderabad MCR Telangana 508126
Hyderabad
TELANGANA
508126
India 
Phone  9493980850  
Fax    
Email  mishusingla@gmail.com  
 
Source of Monetary or Material Support  
AIIMS, Bibinagar Rangapur village, Bibinagar mandal, Yadadri . Telangana - 508126, India  
 
Primary Sponsor  
Name  AIIMS Bibinagar 
Address  AIIMS, bibinagar Rangapur village, bibinagar mandal, yadadri telangana- 508126, India  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR Mishu Mangla   AIIMS Bibinagar  Department of OBGY AIIMS Bibinagar Rangapur village, Bibinagar mandal, Yadadri Hyderabad MCR pincode- 508126 , India
Hyderabad
TELANGANA 
9493980850

mishusingla83@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics commmittee (AIIMS BBN-IEC)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N959||Unspecified menopausal and perimenopausal disorder,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  80.00 Year(s)
Gender  Female 
Details  1. Women undergoing oophorectomy (either unilateral or bilateral) for benign gynaecological conditions or for malignant conditions other than cancer ovary.
2. includes both Premenopausal women and Postmenopausal women.
 
 
ExclusionCriteria 
Details  1.Women with known ovarian malignancies or other serious systemic diseases.
2.Women on long-term hormonal therapy (e.g., oral contraceptives, HRT)
3.Women with a history of pelvic radiation or chemotherapy
4.Malignant ovarian pathology on histopathology.
5. Women with prior ovarian surgeries that could alter fibrosis assessment.
6.Known genetic or autoimmune disorders affecting ovarian reserve.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To study the correlation between the degree of stromal fibrosis and ovarian reserve markers (AMH, FSH, AFC, stomal blood flow and ovarian volume) in perimenopausal women undergoing oophorectomy.
 
within one week of planned surgery.  
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate whether the degree of stromal fibrosis is associated with clinical characteristics (age, menstrual history) & surgical outcomes (complications, recovery time).  Immediately post surgery 
 
Target Sample Size   Total Sample Size="58"
Sample Size from India="58" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   14/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Title of the study: Comparative Analysis of Stromal Fibrosis and Ovarian Reserve in Premenopausal and Postmenopausal Women Undergoing Oophorectomy: an observational  study. 

Novelty/ Innovation

1.  While studies have explored ovarian reserve and fibrosis independently, few have directly compared stromal fibrosis between premenopausal and postmenopausal women undergoing oophorectomy, this study provides insight into age-related fibrotic changes in ovarian stroma and their correlation with ovarian reserve.
2. This study correlates histological fibrosis with ovarian reserve, offering a pathophysiological perspective on ovarian aging.

3. Understanding the role of stromal fibrosis in ovarian aging could have implications for fertility preservation, hormone replacement therapy, and predicting ovarian function decline, especially in premenopausal women undergoing oophorectomy for benign conditions. 


 sample size. 

we used a study that had assessed the ovarian AFC and serum levels of AMH correlation with the ovarian primordial follicle number (1). They found that correlation between the ovarian primordial follicle count and AMH was 0.48.

Considering a correlation coefficient of 0.48, 5% significance level, 80% power, and two tailed test, the required sample size is 29 participants per group, calculated with the help of the following formula.

 


Methods:

1. Recruitment and Data Collection:

         Informed consent will be obtained from all participants

         Detailed medical history, including menstrual history, family history of ovarian diseases, and comorbid conditions, will be collected.

        Participants will undergo clinical assessment to confirm their perimenopausal status, including serum FSH, AMH, Estradiol and AFC and ovarian volume, ovarian stromal blood flow measurement via ultrasound.

2. Ovarian Tissue Collection

    Oophorectomy (unilateral or bilateral) will be performed under standard surgical protocols for indicated benign condition

    Ovarian tissues will be preserved for histopathological examination.

3. Histopathological Examination of Stromal Fibrosis:

     The primary pathological features of ovarian fibrosis are a thick capsule, increased mesenchymal connective tissue, and decreased or absent follicles (2)

     Representative tissue samples (entire cross-section of the ovary) from the included cases will be fixed in either 10% Formalin and will be processed as per standard protocol.

      Haematoxylin and eosin (H&E) stained slides and Masson trichrome stained slides of each case will be evaluated for the degree of stromal fibrosis using a semi-quantitative scale  (Grade 0: No fibrosis; Grade 1: Mild fibrosis; Grade 2: Moderate fibrosis; Grade 3: Severe fibrosis) depending upon the area of fibrosis (3, 4).

            Other histopathological findings will also be documented

    Next, only the cases that show grade 1 to 3 fibrosis, will be stained using a Picrosirius Red solution, which consists of Sirius Red F3B dye dissolved in a saturated aqueous solution of picric acid.

 After staining, the sections will be washed in acidified water (0.5% acetic acid) to remove excess stain.

      The stained slides will be analysed under bright-field microscopy, wherein the collagen will appear red against a yellow background.

       The stained slides will also be analysed under polarized light microscopy, wherein the birefringent properties of collagen will differentiate thick fibres (type I, appearing yellow-orange) from thin fibres (type III, appearing green).

         Semi-quantitative assessment of degree of type 1 fibres and type III fibres will be done (4).

         Fibre orientation, whether the collagen fibres are randomly arranged or aligned in a specific direction, will also be documented.

4. Biochemical Markers of Ovarian Reserve

Anti-Müllerian Hormone (AMH)

Follicle-Stimulating Hormone (FSH)

Antral Follicle Count (AFC) and Ovarian volume- 

 
Close